Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2025-10-29 00:00:00 ET · period of report 2025-10-27 · accession 0001470831-25-000278 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-10-29 | 2025-10-27 | BBIO | MCCORMICK FRANK | Dir | S - Sale | $65.00 | -1,641 | 878.3K | -0.2% | -$106.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-27 | S | D | 1,641 | $65.00 | 878,338 | I By the Francis P. McCormick Rev Trust U/A DTD 1/27/2017 | — | — |